School of Kinesiology and Health Studies, Queen's University
Kingston, Ontario, K7L 3N6, Canada
NCT Number: NCT00955071
The investigators will randomize abdominally obese men and women at increased health risk to one of the following 4 conditions: 1) No-exercise, wait list controls (C), 2) Low volume, low intensity exercise (LVLI), 3) High volume, low intensity exercise (HVLI), 4) Low volume, high intensity exercise (LVHI).
The primary aim of the trial is to determine the effects of varying exercise dose (energy expenditure, kcal) or intensity (relative to VO2max (cardiorespiratory fitness)) on waist circumference and glucose tolerance. The investigators will test the following hypotheses: 1) That the reduction in waist circumference and improvement in glucose tolerance in response to all treatments will be greater than controls. 2) That reduction in waist circumference and improvement in glucose tolerance in HVLI and LVHI will be greater than LVLI. 3) That hypotheses 1 and 2 are true independent of gender.
Looking for future studies?
Notify Me35 year–60 year
All sexes
Interventional
Not applicable
Kingston, Ontario, K7L 3N6, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
low volume, low intensity
high volume, low intensity
low volume, high intensity
Time frame: 6 months
Time frame: 6 months
Queen's University
Other
Dose-response Effects of Exercise on Abdominal Obesity and Risk Factors for CVD in Men and Women.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01023646
Body Weight, Cardiovascular Disease
Boston, Massachusetts, United States
View Trial DetailsNCT01087086
Body Weight, Cardiovascular Disease
Pamplona, Navarre, Spain
View Trial DetailsNCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial Details